Abstract
Background
Sarcopenia is an age-related clinical syndrome characterized by loss of muscle mass and reduced muscle function. Diseases that contribute to sarcopenia include type 2 diabetes mellitus (T2DM), chronic obstructive pulmonary disease (COPD), heart failure, chronic kidney disease, and cancer and others. Fung FY et al. (BMC Geriatrics. 2019;19(1):122) conducted a single-center study aimed to determine the prevalence of sarcopenia among older patients with T2DM and to identify factors which mitigate sarcopenia. Their study entitled “Prevalence of and factors associated with sarcopenia among multi-ethnic ambulatory older Asians with type 2 diabetes mellitus in a primary care setting” suggested that the prevalence of sarcopenia in older patients with T2DM was 27.4%, and that Chinese ethnicity was associated with a greater risk of sarcopenia in the study population.
Discussion
Deficiency in scientific research and analysis of other diseases associated with sarcopenia such as COPD, may contribute to misestimation of the prevalence of sarcopenia in older patients with T2DM. We are concerned that the conclusions of this single-center study with a small study population might be unreliable.
Summary
The prevalence of sarcopenia in older patients with T2DM in a single-center study with a small sample size may be misestimated due to the lack of strict exclusion criteria and detailed analysis of other diseases that contribute to sarcopenia. In addition, it is inappropriate to draw the conclusion that Chinese ethnic group was associated with a greater risk of sarcopenia among the study population.
Keywords: Sarcopenia, Diabetes, COPD
Main text
We read the article “Prevalence of and factors associated with sarcopenia among multi-ethnic ambulatory older Asians with type 2 diabetes mellitus in a primary care setting” with great interest [1]. This study reported that the prevalence of sarcopenia in unassisted ambulatory older, community-dwelling patients with type 2 diabetes mellitus (T2DM) in Singapore was 27.4%, and that Chinese ethnicity was associated with a greater risk of sarcopenia among the study population.
Chronic obstructive pulmonary disease (COPD) can lead to malnutrition, weight loss and induce the development of sarcopenia [2]. The prevalence of sarcopenia in patients with COPD is up to 15–40% [3–6]. In addition to COPD and T2DM, sarcopenia has previously been reported to be associated with various diseases, such as chronic heart failure, chronic kidney disease and cancer. We cannot find the strict exclusion or detailed analysis of the diseases related to sarcopenia in this study. Since this was a single-center research with a small study population, the prevalence of sarcopenia in older patients with T2DM may be largely affected by other diseases such as COPD, among whom the prevalence of sarcopenia is also considerable. Did the authors analyze whether the patients in the sarcopenia and severe sarcopenia groups have complicating COPD or other diseases contributing to sarcopenia? Furthermore, the morbidities of sarcopenia in different ethnicities may be influenced by many factors, and it is inappropriate to draw the conclusion that Chinese ethnic groups were associated with a greater risk of sarcopenia among older patients with T2DM. For example, genetic background plays an important role in the development of COPD, and the morbidity of COPD differs in ethnicities. Did the authors analyze whether the prevalence of COPD in patients of Chinese ethnicity was higher than that in other ethnicities among the study population? Inappropriate and unscientific research design can lead to unreliable results. Did Fung FY et al. take all these questions into consideration? The ignorance of these above issues could affect the results and interpretation of the study. Further studies and analyses should be performed taking into consideration the concerns we have mentioned.
Acknowledgements
Not applicable.
Abbreviations
- T2DM
Type 2 diabetes mellitus
- COPD
Chronic obstructive pulmonary disease
Authors’ contributions
XL conceived the idea and was a major contributor in writing the manuscript. FX, LH, and HF re-analyzed the published study, interpreted and reported the final conclusion. YA critically revised the manuscript. All authors reviewed and finalized the manuscript. All authors read and approved the final manuscript.
Funding
None.
Availability of data and materials
Not applicable.
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Footnotes
The correspondence article is a response to BGTC-D-18-00596 / 10.1186/s12877-019-1137-8
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Contributor Information
Xueting Li, Email: 1652651949@qq.com.
Fengqiang Xu, Email: fengqiangxu@yeah.net.
Longgang Hu, Email: lxtqdu@126.com.
Hao Fang, Email: haofrz@hotmail.com.
Yi An, Email: anyqingdao@hotmail.com.
References
- 1.Fung FY, Koh YLE, Malhotra R, Ostbye T, Lee PY, Shariff Ghazali S, et al. Prevalence of and factors associated with sarcopenia among multi-ethnic ambulatory older Asians with type 2 diabetes mellitus in a primary care setting. BMC Geriatr. 2019;19(1):122. doi: 10.1186/s12877-019-1137-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Wagner PD. Possible mechanisms underlying the development of cachexia in COPD. Eur Respir J. 2008;31(3):492–501. doi: 10.1183/09031936.00074807. [DOI] [PubMed] [Google Scholar]
- 3.Jones SE, Maddocks M, Kon SS, Canavan JL, Nolan CM, Clark AL, et al. Sarcopenia in COPD: prevalence, clinical correlates and response to pulmonary rehabilitation. Thorax. 2015;70(3):213–218. doi: 10.1136/thoraxjnl-2014-206440. [DOI] [PubMed] [Google Scholar]
- 4.Byun MK, Cho EN, Chang J, Ahn CM, Kim HJ. Sarcopenia correlates with systemic inflammation in COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:669–675. doi: 10.2147/COPD.S130790. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.de Blasio F, Di Gregorio A, de Blasio F, Bianco A, Bellofiore B, Scalfi L. Malnutrition and sarcopenia assessment in patients with chronic obstructive pulmonary disease according to international diagnostic criteria, and evaluation of raw BIA variables. Respir Med. 2018;134:1–5. doi: 10.1016/j.rmed.2017.11.006. [DOI] [PubMed] [Google Scholar]
- 6.Limpawattana P, Inthasuwan P, Putraveephong S, Boonsawat W, Theerakulpisut D, Sawanyawisuth K. Sarcopenia in chronic obstructive pulmonary disease: a study of prevalence and associated factors in the southeast Asian population. Chron Respir Dis. 2018;15(3):250–257. doi: 10.1177/1479972317743759. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Not applicable.